Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 4, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 4, 2015Completed
Condition(s):Schizophrenia, Schizoaffective DisorderLast Updated:March 19, 2024Not yet recruiting
Condition(s):SchizophreniaLast Updated:July 28, 2014Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 29, 2021Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Quality of LifeLast Updated:January 16, 2013Unknown status
Condition(s):Mental DisordersLast Updated:October 10, 2012Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:December 5, 2018Completed
Condition(s):Schizophrenia; Schizo Affective Disorder; PsychosisLast Updated:July 30, 2018Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:January 15, 2008Completed
Condition(s):SchizophreniaLast Updated:August 21, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.